News Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Market Closed - Deutsche Boerse AG Other stock markets 02:02:17 2024-04-18 am EDT			5-day change	1st Jan Change
0.0055 ^EUR	-21.43%		-57.69%	-56.00%

Apr. 17	Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Apr. 15	Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	Apr. 16	CI
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	Apr. 15	CI
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs	Dec. 06	CI
XTACY Therapeutics Announces Debt Settlement	23-10-05	NE
Global Wellness Strategies Inc. will Change its Name to XTACY Therapeutics Corp	23-09-25	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-23	CI
Global Wellness Strategies : Voting Instruction Form (“VIF”) – Annual General Meeting to be held on Wednesday, August 16, 2023	23-07-17	PU
Global Wellness Strategies : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 16, 2023	23-07-17	PU
Global Wellness Strategies : GWS NEWS RELEASE	23-04-18	PU
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-04-17	CI
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-04-03	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-03-29	CI
Global Wellness Strategies Inc. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
Global Wellness Strategies : Files Annual Statements September 2022	23-03-28	PU
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials	22-11-17	CI
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings	22-10-31	CI
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-09-02	CI
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings	22-08-02	CI
Global Wellness Strategies : Information Circular	22-07-29	PU
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Summary

Filters